Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial

Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, Kanzo Amano, Ryuji Nagamine, Won Park, Kazuko Shiozawa, Michishi Tsukano, James Cheng Chung Wei, Jing Shao, Osamu Togo, Hideki Mashimo

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences